Ring Christineinsider trades
In SEC Form 4 filings, Ring Christine is listed as Chief Legal Officer of Nurix Therapeutics, Inc. (NRIX). In the last 90 days, Ring Christine sold $283.2K of Nurix Therapeutics, Inc. (NRIX) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| NRIXNurix Therapeutics, Inc. | Chief Legal Officer | 7 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| NRIXNurix Therapeutics, Inc. | Oct 2 | Oct 2 | M | 5,786 | $8.72 | $50,454 | 14,896 | Yes | Form 4 |
| NRIXNurix Therapeutics, Inc. | Oct 2 | Oct 2 | S | 5,786 | $23.19 | Sale −$134,149 | 9,110 | Yes | Form 4 |
| NRIXNurix Therapeutics, Inc. | Oct 2 | Oct 2 | M · derivative | 5,786 | $8.72 | $50,454 | 111,251 | Yes | Form 4 |
| NRIXNurix Therapeutics, Inc. | Sep 2 | Sep 2 | M | 5,787 | $8.72 | $50,463 | 14,897 | Yes | Form 4 |
| NRIXNurix Therapeutics, Inc. | Sep 2 | Sep 2 | S | 5,387 | $25.69 | Sale −$138,417 | 9,510 | Yes | Form 4 |
| NRIXNurix Therapeutics, Inc. | Sep 2 | Sep 2 | S | 400 | $26.64 | Sale −$10,655 | 9,110 | Yes | Form 4 |
| NRIXNurix Therapeutics, Inc. | Sep 2 | Sep 2 | M · derivative | 5,787 | $8.72 | $50,463 | 117,037 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.